Pos Combo 45

Pos Combo 46

Pos MIC 38

Neg MIC 53

Neg MIC 54

Neg Urine Combo 84

Neg Urine Combo 85

Neg Urine Combo 86

Neg Urine Combo 87

Neg Urine Combo 88

LabPro-MBT software is a functional subset of LPDMS intended to electronically transfer and display organism identifications from the Bruker MALDI Biotyper System to theLabPro Data Management System. LabPro-MBT software is a device that is intended to electronically transfer medical device data, without controlling or altering the functions or parameters of any connected medical devices.

Neg MIC 56

Neg Urine Combo 89

Neg Urine Combo 90

DVD, LabPro V5.00 Data Delivery-01 (US, FMR)

Neg Urine Combo 101

Neg Urine Combo 102

Neg Urine Combo 103

LabPro V5.0 Panel Update 10 (US), Electronic - C90679; DVD, LabPro V5.0 Panel Update 10 (US) - C90680

DVD, LabPro V4.42 Panel Update-09 (US); LabPro V4.42 Panel Update-09 DVD Kit (US); LabPro V4.42 System Kit w/Panel Update-09 (US)

DVD, LabPro V4.42 Panel Update-08 (US); LabPro V4.42 Panel Update-08 DVD Kit (US); LabPro V4.42 System Kit w/Panel Update-08 (US)

CD, Labpro V4.42 Panel Update-07LabPro V4.42 Panel Update-07 Kit (US, OUS)LabPro V4.42 System Kit wPanel Update-07 (US,OUS)

The Aptima® Auto Detect Kit. This kit is to be used with the Leader® HC+ Luminometer and the Tigris® instrument system.

Aptima Combo 2® Assay, 100 test, box 2 of 2 (15°C to 30°C box). The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal urogenital disease using the Tigris® DTS® Automated Analyzer or semi-automated instrumentation as specified.

Aptima Combo 2® Assay, 100 test, box 1 of 2 (2°C to 8°C box). The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal urogenital disease using the Tigris® DTS® Automated Analyzer or semi-automated instrumentation as specified.

The Aptima® Specimen Transfer Kit consists of transfer tubes containing specimen transport medium (STM) and is intended for use with Aptima® assays. Refer to the appropriate product package insert for the indicated uses of the Aptima® Specimen Transfer Kit for each Hologic product.

Aptima Combo 2® Assay, 250 test, box 2 of 2 (15°C to 30°C box). The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal urogenital disease using the Tigris® DTS® Automated Analyzer or semi-automated instrumentation as specified.

Aptima Combo 2® Assay, 250 test, box 1 of 2 (2°C to 8°C box). The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal urogenital disease using the Tigris® DTS® Automated Analyzer or semi-automated instrumentation as specified.

The Aptima® System Fluid Preservative Kit is used with the Aptima® Assays on the Tigris® DTS® System. Use the System Fluid Preservative Kit according to the instructions outlined in the appropriate assay package insert and the Tigris® DTS® System Operator’s Manual.

The Aptima® Assay Fluids Kit is used with the Aptima® Assays on the Tigris® DTS® System. Use the Assay Fluids Kit according to the instructions outlined in the appropriate assay package insert and the Tigris® DTS® System Operator’s Manual.

Aptima Combo 2® Assay, 100 test, box 1 of 2 (2°C to 8°C box). The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal disease using the Panther® System as specified.

Aptima® CT assay, 100 test, box 1 of 2 (2°C to 8°C box). The Aptima® Chlamydia trachomatis assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) to aid in the diagnosis of chlamydial urogenital disease using the Tigris® DTS® Automated Analyzer or semi-automated instrumentation as specified.

Aptima® GC assay, 100 test, box 1 of 2 (2°C to 8°C box). The Aptima® Neisseria gonorrhoeae assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection of ribosomal RNA (rRNA) from Neisseria gonorrhoeae (GC) to aid in the diagnosis of gonococcal urogenital disease using the Tigris® DTS® System or semi-automated instrumentation as specified.

Aptima Combo 2® Assay, 100 test, box 2 of 2 (15°C to 30°C box). The Aptima Combo 2® Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal disease using the Panther® System as specified.

Aptima® CT assay, 100 test, box 2 of 2 (15°C to 30°C box). The Aptima® Chlamydia trachomatis assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) to aid in the diagnosis of chlamydial urogenital disease using the Tigris® DTS® Automated Analyzer or semi-automated instrumentation as specified.

Aptima® GC assay, 100 test, box 2 of 2 (15°C to 30°C box). The Aptima® Neisseria gonorrhoeae assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection of ribosomal RNA (rRNA) from Neisseria gonorrhoeae (GC) to aid in the diagnosis of gonococcal urogenital disease using the Tigris® DTS® System or semi-automated instrumentation as specified.

The Aptima® Auto Detect Kit is for use on the Panther® System.

The Aptima® Assay Fluids Kit is for use on the Panther® System.

Panther® Instrument System.

Aptima® HIV-1 Quant Dx Assay.

Aptima® Specimen Diluent.

Aptima® HIV-1 Quant Dx Assay Calibrator.

Aptima® HIV-1 Quant Dx Assay Controls Kit.

The Access PCT assay is a paramagnetic, chemiluminescent immunoassay for in vitro quantitative determination of procalcitonin (PCT) levels in human serum and plasma (lithium heparin and EDTA) using the Access Immunoassay Systems. Measurement of PCT in conjunction with other laboratory findings and clinical assessments aids in the risk assessment of critically ill patients on their first day of Intensive Care Unit (ICU) admission for progression to severe sepsis and septic shock.